𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PO10-TU-68 Coincidence of brain demyelination in multiple sclerosis and systemic inflammatory diseases

✍ Scribed by I. Woznicová; O. Zapletalová; O. Zapletalová; P. Hradılek; J. Havelka

Book ID
119468166
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
44 KB
Volume
285
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Current Topics in Microbiology and Immu
[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease
✍ Scarisbrick, I. A. (author) 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 230 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people

[Current Topics in Microbiology and Immu
[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease
✍ Scarisbrick, I. A. (author) 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 230 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people